+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluticasone"

From
Anti-Asthmatics and COPD Drugs Market Report 2025 - Product Thumbnail Image

Anti-Asthmatics and COPD Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
BREO Ellipta Drugs Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

BREO Ellipta Drugs Market - Global Forecast Report 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Breo Ellipta - Product Thumbnail Image

Breo Ellipta

  • Report
  • July 2018
  • 41 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Fluticasone is a corticosteroid used to treat asthma and other respiratory conditions. It is used to reduce inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. Fluticasone is available in both inhaler and nasal spray forms, and is often prescribed in combination with other asthma medications. It is generally considered to be a safe and effective treatment for asthma, although it can cause side effects such as headaches, nausea, and throat irritation. Fluticasone is one of the most commonly prescribed asthma drugs, and is widely available in both generic and brand-name forms. It is available from a variety of pharmaceutical companies, including GlaxoSmithKline, Merck, and Mylan. Other companies that produce fluticasone-containing products include Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more